Structure Therapeutics (GPCR) News Today $20.57 +0.13 (+0.64%) As of 01:30 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock GPCR Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Structure Therapeutics Inc. Sponsored ADR (NASDAQ:GPCR) Receives Average Rating of "Buy" from BrokeragesJuly 3 at 2:55 AM | marketbeat.comStructure Therapeutics (NASDAQ:GPCR) Shares Down 4% - Here's WhyJune 26, 2025 | marketbeat.comStructure Therapeutics' (GPCR) Market Outperform Rating Reaffirmed at JMP SecuritiesJune 25, 2025 | americanbankingnews.comJefferies Reiterates a Buy Rating on Structure Therapeutics (GPCR) With a $79 PTJune 24, 2025 | msn.comStructure Therapeutics' (GPCR) "Overweight" Rating Reaffirmed at Cantor FitzgeraldJune 24, 2025 | americanbankingnews.comStructure Therapeutics (NASDAQ:GPCR) Shares Up 4.7% - Time to Buy?June 23, 2025 | marketbeat.comCantor Fitzgerald Reaffirms "Overweight" Rating for Structure Therapeutics (NASDAQ:GPCR)June 23, 2025 | marketbeat.comJMP Securities Reiterates "Market Outperform" Rating for Structure Therapeutics (NASDAQ:GPCR)June 23, 2025 | marketbeat.comStructure Therapeutics Announces Two Late-Breaking Poster Presentations at the American Diabetes Association 85th Scientific Sessions Including New Preclinical Data for Oral Small Molecule Amylin Agonist, ACCG-2671June 20, 2025 | globenewswire.comHandelsbanken Fonder AB Buys 215,000 Shares of Structure Therapeutics Inc. (NASDAQ:GPCR)June 13, 2025 | marketbeat.comStructure Therapeutics (NASDAQ:GPCR) Trading Down 4.5% - Time to Sell?June 12, 2025 | marketbeat.comStructure Therapeutics (NASDAQ:GPCR) Shares Up 9.4% - Still a Buy?June 11, 2025 | marketbeat.comEquities Analysts Set Expectations for GPCR FY2026 EarningsJune 11, 2025 | marketbeat.comCantor Fitzgerald Predicts GPCR FY2025 EarningsJune 10, 2025 | marketbeat.comStructure Therapeutics: Why Aleniglipron's Path To Market Remains TreacherousJune 10, 2025 | seekingalpha.comStructure Therapeutics Inc. (NASDAQ:GPCR) Given Average Recommendation of "Buy" by BrokeragesJune 8, 2025 | marketbeat.comBank of America Corp DE Has $1.47 Million Position in Structure Therapeutics Inc. (NASDAQ:GPCR)June 5, 2025 | marketbeat.comUniversal Beteiligungs und Servicegesellschaft mbH Makes New $3.09 Million Investment in Structure Therapeutics Inc. (NASDAQ:GPCR)June 3, 2025 | marketbeat.comBNP Paribas Financial Markets Makes New $304,000 Investment in Structure Therapeutics Inc. (NASDAQ:GPCR)May 29, 2025 | marketbeat.comStructure Therapeutics (NASDAQ:GPCR) Stock Price Down 4.6% - Here's WhyMay 28, 2025 | marketbeat.comZimmer Partners LP Sells 154,200 Shares of Structure Therapeutics Inc. (NASDAQ:GPCR)May 23, 2025 | marketbeat.comVestal Point Capital LP Raises Stock Holdings in Structure Therapeutics Inc. (NASDAQ:GPCR)May 21, 2025 | marketbeat.comWexford Capital LP Sells 16,351 Shares of Structure Therapeutics Inc. (NASDAQ:GPCR)May 21, 2025 | marketbeat.comTema Etfs LLC Acquires New Shares in Structure Therapeutics Inc. (NASDAQ:GPCR)May 20, 2025 | marketbeat.comStructure Therapeutics Inc. (NASDAQ:GPCR) Shares Sold by Point72 Europe London LLPMay 18, 2025 | marketbeat.comStructure Therapeutics Inc. (NASDAQ:GPCR) Receives Average Recommendation of "Buy" from AnalystsMay 16, 2025 | marketbeat.comStructure Therapeutics Inc. (NASDAQ:GPCR) Holdings Boosted by Janus Henderson Group PLCMay 15, 2025 | marketbeat.comEnsign Peak Advisors Inc Has $8.36 Million Stock Holdings in Structure Therapeutics Inc. (NASDAQ:GPCR)May 15, 2025 | marketbeat.comAmeriprise Financial Inc. Increases Stock Position in Structure Therapeutics Inc. (NASDAQ:GPCR)May 15, 2025 | marketbeat.comHC Wainwright Issues Pessimistic Forecast for Structure Therapeutics (NASDAQ:GPCR) Stock PriceMay 14, 2025 | marketbeat.comThe Manufacturers Life Insurance Company Has $1.58 Million Position in Structure Therapeutics Inc. (NASDAQ:GPCR)May 13, 2025 | marketbeat.comFY2025 Earnings Forecast for GPCR Issued By Leerink PartnrsMay 13, 2025 | marketbeat.comVoya Investment Management LLC Sells 20,830 Shares of Structure Therapeutics Inc. (NASDAQ:GPCR)May 11, 2025 | marketbeat.comDeerfield Management Company L.P. Series C Has $10.13 Million Stock Holdings in Structure Therapeutics Inc. (NASDAQ:GPCR)May 10, 2025 | marketbeat.comDriehaus Capital Management LLC Decreases Position in Structure Therapeutics Inc. (NASDAQ:GPCR)May 10, 2025 | marketbeat.comDeep Track Capital LP Acquires 1,579,492 Shares of Structure Therapeutics Inc. (NASDAQ:GPCR)May 9, 2025 | marketbeat.comStructure Therapeutics Reports First Quarter 2025 Financial Results and Recent HighlightsMay 9, 2025 | finance.yahoo.comBaker BROS. Advisors LP Acquires 276,065 Shares of Structure Therapeutics Inc. (NASDAQ:GPCR)May 6, 2025 | marketbeat.comBVF Inc. IL Reduces Stock Position in Structure Therapeutics Inc. (NASDAQ:GPCR)May 6, 2025 | marketbeat.comBellevue Group AG Reduces Stake in Structure Therapeutics Inc. (NASDAQ:GPCR)May 6, 2025 | marketbeat.comStructure Therapeutics (NASDAQ:GPCR) Coverage Initiated by Analysts at CitigroupMay 4, 2025 | marketbeat.comBoxer Capital Management LLC Makes New $13.56 Million Investment in Structure Therapeutics Inc. (NASDAQ:GPCR)May 4, 2025 | marketbeat.comStructure Therapeutics Inc. (NASDAQ:GPCR) Shares Sold by RA Capital Management L.P.May 3, 2025 | marketbeat.comStructure Therapeutics (GPCR) to Release Quarterly Earnings on ThursdayMay 3, 2025 | marketbeat.comStructure Therapeutics (NASDAQ:GPCR) Sets New 12-Month High - Should You Buy?May 3, 2025 | marketbeat.comCitigroup Initiates Coverage of Structure Therapeutics Inc. - Depositary Receipt () (GPCR) with Buy RecommendationMay 3, 2025 | msn.comStructure draws new Buy at Citi on oral obesity drug pipelineMay 2, 2025 | msn.comMonashee Investment Management LLC Sells 27,608 Shares of Structure Therapeutics Inc. (NASDAQ:GPCR)May 2, 2025 | marketbeat.comStructure Therapeutics Inc. (NASDAQ:GPCR) Holdings Decreased by Price T Rowe Associates Inc. MDMay 2, 2025 | marketbeat.com24,530 Shares in Structure Therapeutics Inc. (NASDAQ:GPCR) Acquired by Mariner LLCMay 2, 2025 | marketbeat.com Get Structure Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for GPCR and its competitors with MarketBeat's FREE daily newsletter. Email Address GPCR Media Mentions By Week GPCR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GPCR News Sentiment▼1.040.57▲Average Medical News Sentiment GPCR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GPCR Articles This Week▼25▲GPCR Articles Average Week Get Structure Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for GPCR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Axsome Therapeutics News Akero Therapeutics News Vaxcyte News ADMA Biologics News PTC Therapeutics News Rhythm Pharmaceuticals News Cytokinetics News Krystal Biotech News Zai Lab News ACADIA Pharmaceuticals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GPCR) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Structure Therapeutics Inc. Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Structure Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
